English
Rilotumumab Biosimilar - Research Grade
Rilotumumab Biosimilar - Research Grade, Human IgG2-Kappa
Artikelnummer
ICH5110-20MG
Verpackungseinheit
20mg
Hersteller
Ichorbio
Verfügbarkeit:
wird geladen...
Preis wird geladen...
Target: HGF
Specificity: Detects human HGF
Purification method: This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Background: Uses the same sequence as the therapeutic antibody Rilotumumab
Concentration: 5mg/ml
Formulation: Sterile, preservative-free, solution in PBS. BSA and Azide free.
Purity: ≥95% monomer by analytical SEC, >95% by SDS Page
Endotoxin: <1EU/mg Determined by LAL gel clotting assay
Use: Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Specificity: Detects human HGF
Purification method: This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Background: Uses the same sequence as the therapeutic antibody Rilotumumab
Concentration: 5mg/ml
Formulation: Sterile, preservative-free, solution in PBS. BSA and Azide free.
Purity: ≥95% monomer by analytical SEC, >95% by SDS Page
Endotoxin: <1EU/mg Determined by LAL gel clotting assay
Use: Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Verwandte Artikel
Markieren Sie die Artikel, um Sie dem Warenkorb hinzuzufügen oder
Immer für Sie da
Gernot Ensinger, M.Sc.
Laurent Haze
